Conditions:   Bladder Cancer;   Cervical Cancer;   Colorectal Cancer;   Endometrial Cancer;   Gastrointestinal Complications;   Long-term Effects Secondary to Cancer Therapy in Adults;   Ovarian Cancer;   Prostate Cancer;   Radiation Toxicity;   Sarcoma;   Testicular Germ Cell Tumor;   Vaginal Cancer
Interventions:   Other: questionnaire administration;   Procedure: gastrointestinal complications management/prevention;   Procedure: quality-of-life assessment
Sponsor:   Royal Marsden NHS Foundation Trust
Recruiting - verified March 2010

Condition:   Advanced Cervical Cancer
Interventions:   Drug: mapatumumab;   Drug: cisplatin;   Radiation: radiotherapy
Sponsors:   University Medical Centre Groningen;   Human Genome Sciences
Active, not recruiting - verified November 2009

Conditions:   Cervical Neoplasia;   HPV Infections
Intervention:  
Sponsor:   National Cancer Institute (NCI)
Recruiting - verified January 2010

Conditions:   Fallopian Tube Cancer;   Ovarian Sarcoma;   Ovarian Stromal Cancer;   Recurrent Cervical Cancer;   Recurrent Endometrial Carcinoma;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Uterine Sarcoma;   Recurrent Vaginal Cancer;   Recurrent Vulvar Cancer;   Stage III Cervical Cancer;   Stage III Endometrial Carcinoma;   Stage III Ovarian Epithelial Cancer;   Stage III Ovarian Germ Cell Tumor;   Stage III Uterine Sarcoma;   Stage III Vaginal Cancer;   Stage III Vulvar Cancer;   Stage IV Endometrial Carcinoma;   Stage IV Ovarian Epithelial Cancer;   Stage IV Ovarian Germ Cell Tumor;   Stage IV Uterine Sarcoma;   Stage IV Vulvar Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vaginal Cancer;   Stage IVB Cervical Cancer;   Stage IVB Vaginal Cancer
Interventions:   Radiation: stereotactic radiosurgery;   Procedure: quality-of-life assessment
Sponsor:   Case Comprehensive Cancer Center
Recruiting - verified March 2010

Condition:   Human Papillomavirus Infections
Intervention:  
Sponsors:   Merck;   Danish Cancer Society;   Icelandic Cancer Society;   The Cancer Registry of Norway;   Karolinska Institutet
Active, not recruiting - verified February 2010

Condition:   Cervical Cancer
Interventions:   Drug: MK1775 + topotecan + cisplatin;   Drug: Comparator: MK1775 + topotecan + cisplatin;   Drug: Comparator: Placebo to MK1775 + topotecan + cisplatin
Sponsor:   Merck
Not yet recruiting - verified February 2010

Condition:   Cervical Cancer
Interventions:   Genetic: proteomic profiling;   Other: laboratory biomarker analysis
Sponsors:   Gynecologic Oncology Group;   National Cancer Institute (NCI)
Not yet recruiting - verified February 2010

Condition:   Uterine Cervical Neoplasms
Intervention:   Drug: [F18]Fluorothymidine
Sponsors:   University of Iowa;   Holden Comprehensive Cancer Center
Recruiting - verified February 2010

Conditions:   Head and Neck Cancer;   Lung Cancer;   Liver Cancer;   Rectal Cancer;   Cervical Cancer
Intervention:   Drug: [F 18]HX4
Sponsor:   Siemens Molecular Imaging
Recruiting - verified February 2010